Abstract. The plasma insulin responses of normal weight and obese, diabetic, and nondiabetic subjects to intravenous glucose was only 30-40% of that seen after oral glucose, indicating that alimentary mechanism(s) in addition to the arterial blood sugar concentration regulate insulin secretion. Observations made in subjects with diverted portal circulation indicate that the alimentary insulinogenic mechanism is located in the intestinal tract. The insulinogenic potency of the alimentary and glycemic stimuli expressed in terms of insulin secretion per gram of glucose were remarkably similar within each group of individuals. Between these groups, however, there were considerable differences. Obesity, with or without associated diabetes, was associated with a true hypersecretory responsiveness, whereas diabetes was characterized, with or without obesity, by a marked impairment in insulin secretion. The experimental design used in these studies permitted quantitation of the magnitude of the glycemic component of an oral glucose load. As a consequence df impaired insulin secretion, a greater than normal proportion of the oral glucose load escapes initial hepatic extraction in the maturity-onset diabetic and enters the peripheral circulation. Therefore, in the noninsulin-requiring maturity-onset diabetic, the glycemic insulinogenic stimulus for a given oral glucose load is significantly greater than in normal subjects and accounts for the excessive plasma insulin responses observed late in -the course of an oral glucose tolerance test.
Introduction
Recent studies have indicated that factor (s) other than the arterial blood glucose level may also play an important role in determining the insulin secretory activity of the pancreatic beta cell. It has been reported, for example, that the plasma insulin response to oral glucose exceeds that ob-served after the intravenous administration of the same glucose load, suggesting that the intestinal absorption of glucose triggers insulin release by a mechanism independent of changes in the arterial glucose level (1) (2) (3) (4) . The experimental designs used in these studies have not permitted quantitative estimates of the relative insulinogenic effects of the arterial blood glucose level and the alimentary mechanism(s) in regulating insulin secretion under physiological and pathological conditions. Such estimates are necessary in order to assess, for example, the importance of differing blood sugar levels as a determinant in the excessive plasma insulin responses to oral glucose observed in many patients with obesity and adult-onset diabetes mellitus. The present study was undertaken to quantitate the differential insulinogenic contributions of the blood sugar level and alimen-1954 Tables, 1959. tary mechanisms in normal weight and obese nondiabetic and diabetic subjects. This was accomplished by determining the plasma insulin secretory responses to oral glucose and following intravenous glucose infusions which reproduced the oral glucose blood sugar levels.
Methods
Subjects. Subjects were divided into four groups based on their weight and response to a 100 g oral glucose tolerance test (Table I ). All obese individuals were at least 60% overweight and none of the diabetic subjects had ever received either insulin or oral hypoglycemic agents. All subjects were tested after an overnight fast (14-18 hr) and had been on a diet estimated to contain in excess of 250 g of carbohydrate daily.
Procedures. Each individual served as his own control when the plasma insulin response to oral versus intravenous glucose was compared. This comparison was accomplished by reproducing with a glucose infusion the venous blood sugar profile observed during the first 3 hr after oral ingestion of 100 g of glucose. The oral glucose load (g/kg body weight) was calculated by assuming complete absorption of glucose from the gastrointestinal tract over a 3 hr period. Complete gastric emptying of the oral glucose load was confirmed in 10 normal, 3 obese nondiabetic, 4 normal weight diabetic, and 3 obese diabetic subjects by intubation with a nasogastric tube under fluoroscopic observation 3 hr after ingestion of 100 g of glucose. The tip of the tube was placed at the pyloric junction, and 50 ml of saline was injected and rapidly withdrawn. Protein-free filtrates (5) of the aspirate were prepared immediately after aspiration and the amount of glucose was determined by the glucose oxidase procedure. Less than 500 mg of glucose was found in the gastric washings in all subjects.
Infusion experiments were performed in the following manner: a 20% solution of glucose was infused with a variable speed Harvard pump into an antecubital vein while the blood sugar level was monitored in a continuous stream of blood introduced into an Autoanalyzer circuit (6, 7) from an indwelling venous catheter in the contralateral arm. The Autoanalyzer system gave a completed chemical analysis within * Represents the sum of the A-V glucose differences at the various times tested. Capillary (Cap) and venous (Ven) blood sugar are in mg/100 ml. § Venous plasma insulin, ,uU/ml. and 12 obese nondiabetic individuals after oral glucose and glucose infusions are shown in Fig. 1 and Table II . The plasma insulin responses to intravenous glucose of both normal and obese subjects averaged between 30 and 40%o of those seen after oral glucose ingestion. The pattern of response also appeared to differ in that maximal plasma insulin levels were reached earlier after oral glucose ingestion (30-60 min) than after intravenous infusion (90-120 min), despite the fact that peak blood sugar levels occurred at the same time under both conditions. Obese subjects secreted 3-5 times more insulin than normal weight subjects (P < 0.001) after both oral glucose ingestion and intravenous glucose infusion.
It was assumed in these studies that duplication with glucose infusion of the venous blood sugar levels observed after oral glucose ingestion also resulted in the development of a comparable arterial blood glucose profile. This proved to be the case in five normal individuals in whom both arterialized capillary and venous blood sugar levels were measured during both oral glucose and glucose infusion (Table III) . In these subjects, as well as the individuals recorded in Fig. 1 venous glucose levels attained were slightly higher during the glucose infusion procedure than after oral glucose ingestion. Under these conditions, the arterialized capillary glucose levels during both test procedures were remarkably similar. Nevertheless, the plasma insulin secretory response in these individuals after intravenous glucose (2644 ± 162 ,uU-min ml-') was less than 40%o of that after glucose ingestion (7688 ± 962 MU-min ml-'). As might be expected from the plasma insulin response, the rate of peripheral glucose utilization also appeared to be more rapid after oral glucose. Thus, if the sum of the A-V differences at the various time periods measured is used as an index of the relative rates of peripheral glucose utilization (Table III) , glucose uptake after oral glucose ingestion (111 ± 9 mg/100 ml) was 76%o faster than that after glucose infusion (63 + 8 mg/100 ml), P < 0.005.
Plasma insulin responses of normal weight and obese diabetic subjects to oral and intravenous glucose. In 12 normal weight and 12 obese diabetic individuals in whom the oral blood glucose profile was reproduced by glucose infusion, the plasma insulin responses to oral glucose were 2-3 times greater (P < 0.005) than those observed after intravenous glucose (Fig. 2, Table II ). This differential insulin response occurred despite the fact that the peak mean blood sugar level reached 90 min after beginning the infusion procedure was almost 20% higher than that attained after oral ingestion in both diabetic groups. Even in these diabetic individuals, obesity was still associated with a significantly greater insulin secretory response to both oral and infused glucose (P < 0.01).
Plasma insulin responses to oral and intra- (Fig. 3) .
,se
Although each of these subjects exhibited a diabetic oral glucose -tolerance response, the infusion glucose load required to reproduce their abnormal oral glucose tolerance curves (1.18 g/kg body weight) closely approximated the infusion load used to establish a "diabetic" blood glucose profile in normal individuals (1.64 g/kg body , weight) and was significantly greater than the load given either normal weight or obese diabetic subjects (0.72 and 0.54 g/kg, respectively; see Table IV) . Furthermore, the plasma insulin responses in these patients to both oral glucose (18,-852 pU-min ml-') and infused glucose (9681 JAUmin ml-') were considerably greater than the responses observed in normal weight and obese diabetic subjects at comparable blood sugar levels.
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and "diabetic" blood glucose profiles. The plasma 15 jects to "normal" and "diabetic" blood glucose profiles are shown in Figs. 4 and 5 and Table II . The insulin secretory responses of normal weight diabetic individuals to a normal glucose profile (565 + 108 uU-min ml-') was less than 30%o of that seen in normal subjects (2088 + 146 /%U-min ml-'). This was despite the fact that the infusion procedure consistently "overshot" the desired blood glucose levels at 60, 90, and 120 min in the diabetic group. A similar impairment in pancreatic insulin secretion of the normal weight diabetic group was also observed in response to a diabetic blood glucose profile (7416 + 990 vs. 2124 + 242 MuU-min ml-l for normal and normal weight diabetics, respectively). In both normal and diabetic subjects, obesity was associated with an excessive plasma insulin response to normal and diabetic infused blood glucose profiles. Obese diabetic subjects, however, exhibited significant impairment in insulin secretion when compared to their obese nondiabetic counterparts, the secretory response being 40 and 18%o of the response seen in appropriate weight control subjects to normal and diabetic blood profiles, respectively. (Table II) .
Glucose loads. The glucose load required to establish a normal glucose profile in normal weight diabetics (0.32 + 0.02 g/kg) was at least 30%o less than that required in normal subjects (0.46 + 0.02 g/kg). Larger differences were observed in the loads needed to produce diabetic profiles: normal, 1.64 + 0.18 g/kg vs. normal weight diabetics, 0.72 ± 0.09 g/kg.
Although obese nondiabetic subjects were classified as nondiabetic on the basis of a 100 g oral glucose tolerance test, the oral glucose load given these individuals, when expressed in terms of body weight (0.69 ± 0.07 g/kg) was significantly less than that ingested by the normal group (1.41 + 0.14 g/kg). Further evidence that carbohydrate tolerance in these obese subjects is severely impaired is the fact that the infusion glucose loads required for normal (0.25 + 0.05 g/kg) and diabetic (0.87 + 0.04 g/kg) blood glucose profiles were comparable to those determined for normal weight diabetics (0.32 + 0.02 g/kg and 0.72 ± 0.09 g/kg, respectively) and 40-50% of the load given normal individuals. The patients with the greatest impairment in carbohydrate tolerance appear to be the obese diabetics since the glucose loads necessary to duplicate normal and diabetic profiles (0.21 + 0.02 g/kg and 0.54 ± 0.05 g/kg)
were considerably less than that infused in normal weight diabetics.
Discussion
The original observations of Straub (10) and Traugott (11) over 45 yr ago and the more recent studies of Conard (12), Dupre (13) , and Somersalo (14) indicating that the oral but not intravenous administration of glucose increased the rate of utilization of a second glucose load led to the suggestion that the insulin secretory response differed quantitatively depending on the route of glucose administration. Evidence supporting this interpretation was first obtained by Elrick et al. (1) and McIntyre et al. (2, 3) who demonstrated that the plasma insulin responses to (16, 17) , secretin (13) , pancreozymin (18) , and possibly other intestinal factors (19) have been reported to stimulate insulin secretion independently of changes in blood sugar. Whether only one or all of these substances function as the physiological mediator(s) of the alimentary component of oral glucose-stimulated insulin secretion remains to be determined.
There are few data in the literature concerning the disposition of an oral glucose load between hepatic uptake and utilization by the peripheral tissues in either man or laboratory animals. Scow and Cornfield (20) reported that, in the rat, approximately 60-65%o of an oral glucose load was taken up by the liver, the remainder entering the systemic circulation. A similar disposition appears to occur in man. In the experimental design used in this study, the intravenous glucose load required to duplicate the oral blood glucose profile can be taken as a close approximation of the quantity of glucose escaping initial hepatic uptake after oral ingestion. In the normal individual, approximately 31 g of a 100 g oral glucose load enters the peripheral circulation (Table VI) and represents the glycemic component of the oral glucose insulinogenic stimulus. In the normal weight diabetic subject, on the other hand, over 50% of the oral glucose load enters the peripheral circulation and this value increases to in excess of 75% in the obese diabetic. Therefore, it is important to recognize that the insulinogenic stimulus of an oral glucose load is a multicomponent one which cannot be expressed simply in terms of the quantity of glucose ingested.
The evolution of an alimentary insulinogenic mechanism would contribute to the maintenance of metabolic homeostasis by insuring the immediate release of insulin coincident with glucose ingestion, thereby accelerating hepatic extraction of absorbed glucose and preventing excessive fluctuations of the peripheral blood sugar and insulin levels. The physiological significance of this insulinogenic mechanism is particularly evident in the diabetic individual. As is evident from Table V is reflected in the delayed rise of peripheral plasma insulin characteristic of the maturity-onset diabetic (21) . Since hepatic glucose uptake is an insulindependent process (22) , a greater than normal proportion of an ingested glucose load will escape hepatic uptake in the diabetic and enter the peripheral circulation.
-The excessive plasma insulin levels seen in many maturity-onset diabetics have been interpreted by some (21, 23) as indicating a hypersecretory responsiveness which has developed secondary to a state of insulin antagonism. The term hypersecretion denotes a greater than normal response to a given stimulus. An essential element in this definition is that the stimulus must be the same both qualitatively and quantitatively. Such is not the case for an oral glucose load given normal and diabetic individuals, as pointed out above, for although the alimentary stimulus is equivalent in both groups, the glycemic insulinogenic component is 60-120% greater in the diabetic subjects (Table   VI) . This difference in the glycemic component readily explains the excessive insulin levels seen in mild diabetics late in the course of an oral glucose tolerance test. When the insulin secretory response of normal and diabetic subjects to an equivalent glycemic stimulus is determined, im. paired insulin secretion is readily demonstrated in both the normal weight and obese diabetic groups (Figs. 4 and 5, Table II) . Furthermore, the diabetic also exhibits a defective insulin response to the alimentary component, as shown in Table V . These results are in agreement with the conclusion recently reported by Seltzer et al. (24) and Cerasi and Luft (25) that insulin secretion is impaired in diabetes mellitus.
An example of true hypersecretory insulin responsiveness is seen in association with obesity. In obese individuals, both nondiabetic and diabetic, the insulin responses to comparable alimentary and glycemic stimuli are two-to fourfold greater than those seen in nondiabetic and diabetic control subjects of normal weight (Table V) . Similar results have been reported by Karam et al. (26) and have also been noted in response to tolbutamide (27) and arginine infusions (28) . The diabetic state does not appear to be associated with an impairment of the biological effectiveness of insulin. Thus, if insulin effectiveness is expressed in terms of a glucose load/insulin secretory response ratio, comparable values ranging from 0.015 to 0.022 are observed in both normal and normal weight diabetic subjects in response to infused normal and diabetic blood glucose profiles. In contrast, the values observed in both obese nondiabetic and diabetic subjects under similar conditions ranged from 0.004 to 0.010, indicating the presence of significant insulin antagonism associated with obesity per se.
